According to Hims & Hers Health's latest financial reports the company has a price-to-book ratio of 15.1.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | N/A | -100% |
2023-12-31 | 5.48 | 28.39% |
2022-12-31 | 4.27 | 7.02% |
2021-12-31 | 3.99 | |
2020-12-31 | N/A | |
2019-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
![]() Organovo ONVO | 3.64 | -75.84% | ๐บ๐ธ USA |
![]() Orchard Therapeutics
ORTX | 4.74 | -68.55% | ๐ฌ๐ง UK |
![]() Novavax NVAX | -2.39 | -115.85% | ๐บ๐ธ USA |
![]() Novocure
NVCR | 5.81 | -61.42% | Jersey |